Phase II Study of Glofitamab With Venetoclax +/- Zanubrutinib in High-risk Mantle-cell Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Clementine SARKOZY, MD
Institut Curie
Study Chair - Gilles CROCHET, MD
CHU Dinant Godinne UCL Namur - YVOIR
Study Chair - Louise ROULIN, MD
Hôpital Henri-Mondor - AP-HP
Study Chair - Steven LE GOUILL, Pr
Institut Curie
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Az Sint-Jan Brugge - Oostende Av
Bruges, Belgium
Recruiting - Institut Jules Bordet
Brussels, Belgium
Recruiting - Chu de Liege
Liège, Belgium
Recruiting - Chu Ucl Namur - Site Godinne
Yvoir, Belgium
Recruiting
- Aphp - Hopital Henri Mondor
Créteil, France
Recruiting - Chu Dijon Bourgogne
Dijon, France
Recruiting - Chu de Lille - Hopital Claude Huriez
Lille, France
Recruiting - Institut Paoli Calmettes
Marseille, France
Recruiting - Chu de Montpellier
Montpellier, France
Recruiting - Chu de Nantes
Nantes, France
Recruiting - Chu Lyon-Sud
Pierre-Bénite, France
Recruiting - Chu de Reims - Hopital Robert Debre
Reims, France
Recruiting - Chu Pontchaillou
Rennes, France
Recruiting - Centre Henri Becquerel
Rouen, France
Recruiting - Institut Curie
Saint-Cloud, France
Recruiting - Hopitaux Universitaires de Strasbourg (hus)
Strasbourg, France
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Feb 2025
- Primary completion
- 31 May 2028
- Completion
- 31 Mar 2032
- Last update posted
- 10 Jul 2026
- Registered enrollment
- 100
- Registry id
- NCT06558604
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.